Fractyl Health (GUTS) Other Accumulated Expenses (2023 - 2026)
Fractyl Health's (GUTS) quarterly Other Accumulated Expenses came in at $596000.0 in Q1 2026, down 92.54% YoY from $8.0 million in Q1 2025, and down 37.98% on a QoQ basis from $961000.0 in Q4 2025.
Fractyl Health (GUTS) Other Accumulated Expenses (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 4 years of Other Accumulated Expenses data on file, last reported at $596000.0 in Q1 2026.
- Quarterly Other Accumulated Expenses fell 92.54% year-over-year to $596000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $596000.0 (down 92.54% YoY) and the FY2025 annual result came in at $961000.0, up 15.64% from the prior year.
- Other Accumulated Expenses fell to $596000.0 in Q1 2026, from $961000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $8.4 million in Q2 2025 to a low of $2000.0 in Q4 2023.
- A 4-year average of $2.6 million and a median of $713500.0 in 2024 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2024 — Other Accumulated Expenses soared 41450.0% — and 2026, when it sank 92.54%.
- Tracing GUTS's Other Accumulated Expenses over 4 years: stood at $2000.0 in 2023, then soared by 41450.0% to $831000.0 in 2024, then climbed by 15.64% to $961000.0 in 2025, then slumped by 37.98% to $596000.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $596000.0 (Q1 2026), $961000.0 (Q4 2025), and $5.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Fractyl Health | 123.81 Mn | 123.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 755,000.00 |
| Mar 31, 2026 | 596,000.00 |
| Dec 31, 2025 | 961,000.00 |
| Sep 30, 2025 | 5.92 Mn |
| Jun 30, 2025 | 8.41 Mn |
| Mar 31, 2025 | 7.99 Mn |
| Dec 31, 2024 | 831,000.00 |
| Sep 30, 2024 | 445,000.00 |
| Jun 30, 2024 | 427,000.00 |
| Mar 31, 2024 | 99,000.00 |
| Dec 31, 2023 | 2,000.00 |